High galectin-3 expression was significantly correlated with worse OS in the patients with HCC (HR = 3.29, 95% CI = 1.62–6.68, p = 0.001) with a significant heterogeneity (I2 = 90.00%, p = 0.008). This evidence concerns the gene LGALS3 and hepatocellular carcinoma.